miR-146a is negatively correlated with anti-dsDNA antibodies and participates in mesenchymal stem cells (MSCs) senescence in SLE patients by targeting TRAF6/NF-κB signal pathway. This evidence concerns the gene TRAF6 and systemic lupus erythematosus.